Feasibility of adjuvant S-1 plus docetaxel against stage II-III gastric cancer following R0 resection in gastrectomy

被引：1
|
作者：
Emi, Y. [1 ]
Orita, H. [2 ]
Yamamoto, M. [3 ,4 ]
Sadanaga, T. [5 ]
Kusumoto, T. [6 ]
Takahashi, I. [7 ]
Kakeji, Y. [1 ]
Maehara, Y. [1 ]
机构：
[1] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan
[2] Saiseikai Yahate Gen Hosp, Kitakyushu, Fukuoka, Japan
[3] Hiroshima Red Cross Hosp, Hiroshima, Japan
[4] Atom Bomb Survivors Hosp, Hiroshima, Japan
[5] Saiseikai Fukuoka Gen Hosp, Fukuoka, Japan
[6] Natl Beppu Med Ctr, Beppu, Oita, Japan
[7] Matsuyama Red Cross Hosp, Matsuyama, Ehime, Japan
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71258-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：372 / 372
页数：1
相关论文
共 50 条
  • [1] Phase II Feasibility Study of Adjuvant S-1 plus Docetaxel for Stage III Gastric Cancer Patients after Curative D2 Gastrectomy
    Tamura, Shigeyuki
    Fujitani, Kazumasa
    Kimura, Yutaka
    Tsuji, Takeshi
    Matsuyama, Jin
    Iijima, Shohei
    Imamura, Hiroshi
    Inoue, Kentaro
    Kobayashi, Kenji
    Kurokawa, Yukinori
    Furukawa, Hiroshi
    ONCOLOGY, 2011, 80 (5-6) : 296 - 300
  • [2] Adjuvant Chemotherapy With S-1 Plus Docetaxel Versus S-1 Plus Oxaliplatin in Stage III Gastric Cancer
    Yamamoto, Masaaki
    Omori, Takeshi
    Shinno, Naoki
    Hara, Hisashi
    Mukai, Yosuke
    Sugase, Takahito
    Takeoka, Tomohira
    Mikamori, Manabu
    Kanemura, Takashi
    Hasegawa, Shinichiro
    Akita, Hirofumi
    Haraguchi, Naotsugu
    Nishimura, Junichi
    Wada, Hiroshi
    Matsuda, Chu
    Yasui, Masayoshi
    Miyata, Hiroshi
    Ohue, Masayuki
    ANTICANCER RESEARCH, 2023, 43 (11) : 5015 - 5024
  • [3] Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
    Noriyuki Hirahara
    Takeshi Matsubara
    Shunsuke Kaji
    Tetsu Yamamoto
    Ryoji Hyakudomi
    Kiyoe Takai
    Kazunari Ishitobi
    Yuki Uchida
    Yoshitsugu Tajima
    BMC Cancer, 21
  • [4] Phase II feasibility study of adjuvant chemotherapy with docetaxel/cisplatin/S-1 followed by S-1 for stage III gastric cancer
    Hirahara, Noriyuki
    Matsubara, Takeshi
    Kaji, Shunsuke
    Yamamoto, Tetsu
    Hyakudomi, Ryoji
    Takai, Kiyoe
    Ishitobi, Kazunari
    Uchida, Yuki
    Tajima, Yoshitsugu
    BMC CANCER, 2021, 21 (01)
  • [5] Feasibility and predictive factors on the completion of docetaxel plus S-1 adjuvant chemotherapy in pathological stage III gastric cancer
    Terayama, Masayoshi
    Ohashi, Manabu
    Yamaguchi, Kensei
    Takahari, Daisuke
    Makuuchi, Rie
    Hayami, Masaru
    Ida, Satoshi
    Kumagai, Koshi
    Sano, Takeshi
    Nunobe, Souya
    ANNALS OF GASTROENTEROLOGICAL SURGERY, 2025, 9 (01): : 60 - 68
  • [6] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0604).
    Matsuyama, Jin
    Tamura, Shigeyuki
    Fujitani, Kazumasa
    Kimura, Yutaka
    Tsuji, Takeshi
    Iijima, Shohei
    Imamura, Hiroshi
    Inoue, Kentaro
    Kobayashi, Kenji
    Kurokawa, Yukinori
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [7] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0604)
    Fujitani, K.
    Tamura, S.
    Kimura, Y.
    Tsuji, T.
    Matsuyama, J.
    Iijima, S.
    Imamura, H.
    Kurokawa, Y.
    Tsujinaka, T.
    Furukawa, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [8] Phase II feasibility study of adjuvant S-1 plus docetaxel for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 1002)
    Matsuyama, Jin
    Fujitani, Kazumasa
    Tamura, Shigeyuki
    Kimura, Yutaka
    Imamura, Hiroshi
    Fujita, Junya
    Iljima, Shohei
    Ueda, Shugo
    Shimokawa, Toshio
    Kurokawa, Yukinori
    Satoh, Taroh
    Tsujinaka, Toshimasa
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [9] Phase II study of docetaxel (DTX) and S-1 as neoadjuvant chemotherapy for potentially R0 advanced gastric cancer
    Emi, Yasunori
    Oki, Eiji
    Saeki, Hiroshi
    Morita, Masaru
    Kusumoto, Tetsuya
    Matsuura, Hiroshi
    Shimokawa, Mototsugu
    Kakeji, Yoshihiro
    Baba, Hideo
    Maehara, Yoshihiko
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (04)
  • [10] Adjuvant Chemotherapy with S-1 plus Cisplatin for Patients with Stage III Gastric Cancer After Curative Resection
    Mita, Kazuhito
    Ito, Hideto
    Ota, Emi
    Takahashi, Koudai
    Hashimoto, Masatoshi
    Asakawa, Hideki
    Hayashi, Takashi
    Fujino, Keiichi
    ANTICANCER RESEARCH, 2017, 37 (03) : 1329 - 1333
12345